Yes indeed sekrub. I'm a patient fellow. SIX continues to...

Yes indeed sekrub. I'm a patient fellow. SIX continues to underperform. I remain confident that they will turn the corner. The fundamental key for me remains that they have a market leading product. It was too expensive to produce, however, they can now have low cost volume manufactoring that will ensure their competiveness on price with other products in the market. They also have volume manufactoring expertise and a new network of contacts, and there appears to be opportunities in the pipeline. I was anticipating stronger global demand in 2012 to flow through to 2013 and that further announcements would ensure a re rating of the share price. However, that hasn't eventuated. I remain optimistic that we'll be rewarded for our patience, although to be fair, I've felt that way for 24 months, and it hasn't come to fruition.